相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The reproductive number of COVID-19 is higher compared to SARS coronavirus
Ying Liu et al.
JOURNAL OF TRAVEL MEDICINE (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B
Wenjun Wang et al.
NATURE NANOTECHNOLOGY (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2
Alba Grifoni et al.
CELL HOST & MICROBE (2020)
Rapid COVID-19 vaccine development
Barney S. Graham
SCIENCE (2020)
Development of an inactivated vaccine candidate for SARS-CoV-2
Qiang Gao et al.
SCIENCE (2020)
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
Shibo Jiang et al.
TRENDS IN IMMUNOLOGY (2020)
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Bin Ju et al.
NATURE (2020)
Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto et al.
NATURE (2020)
Developing Covid-19 Vaccines at Pandemic Speed
Nicole Lurie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
Hui Wang et al.
CELL (2020)
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
Lianpan Dai et al.
CELL (2020)
A Thermostable mRNA Vaccine against COVID-19
Na-Na Zhang et al.
CELL (2020)
Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice
James Brett Case et al.
CELL HOST & MICROBE (2020)
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice
Dorottya Laczko et al.
IMMUNITY (2020)
COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses
Muhammad Adnan Shereen et al.
JOURNAL OF ADVANCED RESEARCH (2020)
Self-assembling influenza nanoparticle vaccines drive extended germinal center activity and memory B cell maturation
Hannah G. Kelly et al.
JCI INSIGHT (2020)
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Feng-Cai Zhu et al.
LANCET (2020)
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
Ahmed O. Hassan et al.
CELL (2020)
Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies
Bingfeng Liu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
Jingyun Yang et al.
NATURE (2020)
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
Noe B. Mercado et al.
NATURE (2020)
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
Neeltje van Doremalen et al.
NATURE (2020)
COVID-19 vaccine development and a potential nanomaterial path forward
Matthew D. Shin et al.
NATURE NANOTECHNOLOGY (2020)
COVIDep: a web-based platform for real-time reporting of vaccine target recommendations for SARS-CoV-2
Syed Faraz Ahmed et al.
NATURE PROTOCOLS (2020)
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Thomas F. Rogers et al.
SCIENCE (2020)
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
Jose Mateus et al.
SCIENCE (2020)
Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits
Supriya Ravichandran et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
B cell memory: building two walls of protection against pathogens
Munir Akkaya et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Zika Virus-Immune Plasmas from Symptomatic and Asymptomatic Individuals Enhance Zika Pathogenesis in Adult and Pregnant Mice
Byoung-Shik Shim et al.
MBIO (2019)
Remembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination
Anna-Karin E. Palm et al.
FRONTIERS IN IMMUNOLOGY (2019)
Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers
Talar Tokatlian et al.
SCIENCE (2019)
Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
Li Liu et al.
JCI INSIGHT (2019)
Viral-Induced Enhanced Disease Illness
Maria K. Smatti et al.
FRONTIERS IN MICROBIOLOGY (2018)
T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
William J. Liu et al.
ANTIVIRAL RESEARCH (2017)
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
Masaru Kanekiyo et al.
NATURE (2013)
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
Joseph Jardine et al.
SCIENCE (2013)
Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
Chien-Te Tseng et al.
PLOS ONE (2012)
Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing
Hatem A. Elshabrawy et al.
PLOS ONE (2012)
Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin
Bijan Zakeri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The spike protein of SARS-CoV - a target for vaccine and therapeutic development
Lanying Du et al.
NATURE REVIEWS MICROBIOLOGY (2009)
分享论文
